USPTO serial 79356269
UNIVERSAL DIAGNOSTICS DX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 11, 2025
- Examiner
- AIKENS, RONALD E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with UNIVERSAL DIAGNOSTICS DX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic products and materials, namely, diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancer and pre-cancer stages; reagents for medical diagnosis, namely, a proprietary mix of nucleic acid PCR primers; diagnosis preparations for medical purposes, namely, medical diagnostic reagents; Diagnostic agents for medical use, namely, medical diagnostic test media in the form of strips for measuring levels of cancer cells in the blood; diagnostic testing materials for medical use, namely, medical diagnostic test strips for use in the field of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for the detection of disease | ACTIVE | — |
| 009 | Downloadable computer software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; Downloadable computer application software for mobile phones, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; Downloadable computer programs for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; downloadable computer software for integrating applications and databases; data processing software, downloadable; software as a medical device, downloadable for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; software being a medical device (SaMD), downloadable for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; downloadable diagnostic software for use in diagnosing cancer and pre-cancer stages; Downloadable electronic publications in the nature of magazines, newsletters in the field of science and medicine | ACTIVE | — |
| 010 | Automatic hematology analyzers for medical diagnostics; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for detecting cancer and pre-cancer; assay instruments, namely, sample preparation devices for medical diagnostic use; apparatus for diagnostic testing for medical purposes, namely, medical diagnostic apparatus for detecting cancer; apparatus for diagnosis of tumors; medical apparatus and instruments for diagnostic use, specifically, diagnostic medical testing apparatus for blood testing for use in the detection of cancer and pre-cancer | ACTIVE | — |
| 035 | Promotional, marketing and advertising services; commercial business management, organization consultation and administration; providing office functions; import-export agency services; wholesale distributorships, retail store services, and online retail store services via global communication networks for diagnostic products and materials, products for medical diagnostics, reagents for medical diagnostics, diagnostic preparations for medical use, diagnostic agents for medical use, diagnostic testing materials for medical use, diagnostic kits composed of medical diagnostic reagents and assays for the detection of disease, downloadable software in the fields of software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment, downloadable computer applications in the fields of software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment, downloadable computer programs in the fields of software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment, computer software for application and database integration, data processing software, software as a medical device, downloadable for prevention, screening, diagnosis, monitoring and treatment in the field of cancer and pre-cancer, software being a medical device [SaMD], downloadable for prevention, screening, diagnosis, monitoring and treatment in the field of cancer and pre-cancer, downloadable diagnostic software for use in diagnosing, downloadable electronic publications in the field of cancer and pre-cancer stages prevention, screening, diagnosis, monitoring and treatment, downloadable publications in electronic form, medical diagnostic instruments, tools for medical diagnostics, automatic analyzers for medical diagnosis, diagnostic apparatus for medical use, assay instruments for medical diagnostic use, apparatus for carrying out diagnostic assays for medical purposes, apparatus for tumor diagnosis, medical apparatus and instruments for diagnostic use, specifically, diagnostic medical testing apparatus, advertising services focused on public awareness in relation to diseases, product demonstration and testing services for assisting in the operation of a commercial company as a franchise promotion of sales, also known as, advertising, including promotion relating to the sale of articles and services for third parties by the transmission of advertising material and the dissemination of advertising messages on computer networks; business assistance, management and administration services; assistance in the management of company activities; commercial management | ACTIVE | — |
| 042 | Scientific and technological services, as well as associated research and design services, namely, DNA analysis and liquid biopsy services using laboratory developed tests in the field of medical and scientific research in the field of cancer and pre-cancer; quality control for others; authentication services, namely, authentication data in the field of medical records using blockchain technology; computer hardware and software design and development for others; development and testing of calculation methods, algorithms and software for others; research relating to medicine; medical laboratory services, namely, DNA analysis and liquid biopsy services using laboratory developed tests in the field of medical and scientific research in the field of cancer and pre-cancer; scientific research for medical purposes in oncology; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus for others; advisory, information and consultancy services in the field of medical testing; services for temporary use of online, non-downloadable software for medical testing; providing temporary use of online, non-downloadable software for quality control systems for medical testing; quality control services for others; quality control services for medical tests; providing temporary use of non-downloadable software to monitor and improve the reliability and quality of medical testing; software as a service (SaaS) services featuring software for analyzing and preparing medical test data reports | ACTIVE | — |
| 044 | Medical services, namely, medical prognosis, diagnosis, analysis, treatment and monitoring services for the detection, prevention, treatment and monitoring of pre-cancer and cancer diseases; healthcare for people; performing diagnosis of diseases; medical diagnostic testing services consisting primarily of chemical analysis and use of bioinformatics tools for cancer detection; medical diagnostic analysis services; medical analyses for the diagnosis and treatment of people; medical analysis for diagnostic or treatment purposes; medical testing relating to the diagnosis and treatment of diseases, namely, next generation sequencing test for diagnosis and treatment of cancer; medical reporting services, namely, issuance of medical reports; medical testing services for cancer diagnosis and prognosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Universal Diagnostics, S.A.
- Other trademarks owned by Universal Diagnostics, S.A.
- Other trademarks owned by Universal Diagnostics, S.A.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named UNIVERSAL DIAGNOSTICS DX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 9, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 9, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 11, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 27, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 1, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 30, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 17, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 18, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |